In brief, MMP-2 and MMP-9 proteins are two crucial facilitators that are conducive to potentiating tumor metastatic and invasive potentials, these therapeutic candidate agents are expected to be used to the clinic CRC treatment and intervention by targeting the two crucial targets. This evidence concerns the gene MMP2 and colorectal carcinoma.